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Tactical operators, inclusive of soldiers in the military, are reliant
upon their physiological and psychological state in often volatile and extreme life or death situations that require correct decisions and precise
actions to ensure operational success with minimal collateral damage.
Accordingly, the development of physical and mental resilience are hallmarks of prophylactic and remedial programs designed to ensure military personnel are combat ready, thus optimising their capacity to
perform at expert levels, while reducing their risk of injury or the severity of injury sustained. Unfortunately, despite best efforts, current practices have not overcome the signiﬁcant logistical challenges confronting
a military service member's routine exposure to moderate and severe
energy deﬁcits upon deployment, resulting from unyielding energy demands and restricted energy intake during missions [1]. Consequently,
these episodes of semi-starvation under complex and extreme tactical
environments produces a cascade of interlinked negative outcomes, including a hypogonadal endocrine state (suppressed testosterone production), loss of muscle-bone mass and strength, reduced functional
capacity, compromised cognition, and a suppressed immune system,
culminating in greater susceptibility to injury, illness and sub-optimal
performance, jeopardising their own welfare and the welfare of their
comrades.
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Normal physiologic levels of serum testosterone expressed in
young men in the United States ranges from 10.4 to 34.7 nmol/L
(300 to 1000 ng/dL) [2]. However, military personnel express up to
65% less serum testosterone as a consequence of stress and duress applied in military training [3], reﬂecting the inevitable response also experienced by deployed military soldiers. To remedy hypogonadal
states induced by moderate-to-severe energy deﬁcits and extreme operational conditions, exogenous testosterone supplementation (testosterone replacement therapy) is a viable countermeasure to effectively
reverse the cascade of physical and mental consequences experienced
by tactical operators [4]. In alignment with clinical treatment of men
with chronically low testosterone levels, the updated Endocrine Society
clinical practice guidelines recommend a wide array of pharmacotherapies, the most prominent of which is testosterone enanthate; an easily administered synthetic derivative of testosterone through
intramuscular injection; to be given at a starting rate of 75–100 mg/week on average [2]. Such strategies in the hypogonadal civilian have
been shown to produce predictable yet important beneﬁts, such as increased myogenesis and osteogenesis (muscle-bone mass and
strength), improved physical function, reduced anxiety, increased
mood, and increased cognition (i.e. attention, visual scanning ability,
executive function and psychomotor speed) [5,6]. These qualities are
critical to the performance of military personnel, though whether testosterone replacement produces equivalent outcomes under
moderate-to-severe energy deﬁcits as a consequence of extreme operational conditions has yet to be clariﬁed.
In EBioMedicine, Pasiakos and colleagues [1] report their initial results from an impressive three-phase, proof-of-concept, randomised,
double-blind, placebo-controlled trial; the ﬁrst known rigorously controlled study exploring this critical research question. We commend
the Military Nutrition Division of the US Army Research Institute of Environmental Medicine and the Pennington Biomedical Research Center
for their ambitious undertaking to pursue this line of inquiry. Using a
14-day eucaloric control period, 28-day intervention of 200 mg/week
testosterone enanthate supplementation with an exercise- and dietinduced energy deﬁcit, and subsequent 14-day ad-libitum recovery
period; this study demonstrated a reduction in weight loss and
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improvement in lean mass gain, producing beneﬁts in body composition and health status. However, the enduring effect of testosterone
enanthate has yet to be realised in their cohort, owing to the shortterm nature and time-points utilised, which may partly explain the
limited bandwidth of positive beneﬁts described. For example,
strength beneﬁts when supplementing with testosterone enanthate
are typically observed after 6 weeks of administration [7] with ergogenic muscle mass increases preceding strength beneﬁts. This may
partly explain the observed increase in muscle mass but not strength
in Pasiakos and colleagues [1], assessed after only 28 days of treatment.
In addition, the single-joint isokinetic muscle function test used in
their trial is limited by mechanical speciﬁcity relative to training and
operations of military personnel, thus may lack sensitivity. The absence
of muscle function improvement in their trial must be considered in
this context.
Replica trials utilising longer-term interventions with longer-term
follow-up would be the next logical step to interrogate the therapeutic
utility of this treatment method for this population. This is vital as the
anabolic effects of testosterone replacement therapy in military personnel has long-term implications [8], including protective effects on muscle and bone (which may prevent stress fractures or load carriage
incidents [5]), and the likely improvement in recovery from completed
missions or injuries sustained. Most critical to the future of this work is
the evident generation and accumulation of myonuclei during hypertrophy [8], as myonuclei do not experience apoptosis during atrophy
or programmed cell death, thus new muscle mass developed during
youth and through ergogenic means provides lasting physiological beneﬁts that facilitates faster re-growth of lost muscle [9], faster re-gain of
lost muscle strength, and faster recovery in unavoidable cases where atrophy has to occur. This also has considerable potential to delay the
onset of sarcopenia and osteoporosis later in life; a downstream beneﬁt
worthy of exploration. Lastly, controversy surrounding the use of exogenous testosterone and aggressive prostate cancer risk in older age remains unresolved, as prostate cancer is known to thrive in
testosterone rich environments. Fortunately, this does not appear to
be supported in the literature, with increased exogenous or endogenous
testosterone levels in young men not associated with increased risk of
prostate cancer, increased prostate-speciﬁc antigen (PSA) levels or increased prostate cancer aggressiveness at diagnosis [10], which would
otherwise present an ethical dilemma to this treatment pathway in military personnel.
Longer-term companion and observational studies are advised to directly examine many of the implicated and associated beneﬁts and risks
for male military personnel over the mid-to-long term. Furthermore,
with the increased recruitment and integration of female personnel in
to military combat positions, studies evaluating the female endocrine
response to severe stress and its consequences are also needed.
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